COLL
insider transactionsCOLLEGIUM PHARMACEUTICAL, INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-17.3K
0 buy · 17.3K sell
Net value · 90d
-$628.6K
$0 in · $628.6K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
4
0 buy · 17.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Director
$0
8.7K sh
Own New
-
Exercise·M
Director
$143.5K
8.7K sh · $16.49
Own +8%
-
Grant·A
Director
$0
15.5K sh
Own +515%
-
Sell·S
Director
$681
20 sh · $34.05
Own -0%
-
Exercise·M
Director
$0
8.7K sh
Own New
-
Sell·S
Director
$142.5K
4.1K sh · $34.54
Own -5%
-
Exercise·M
Director
$143.5K
8.7K sh · $16.49
Own +11%
-
Grant·A
Director
$0
17.5K sh
Own New
-
Grant·A
Director
$0
8.7K sh
Own +45%
-
Grant·A
Director
$0
8.7K sh
Own +49%
-
Grant·A
Director
$0
8.7K sh
Own +12%
-
Grant·A
Director
$0
8.7K sh
Own +9%
-
Grant·A
Director
$0
8.7K sh
Own +17%
-
Grant·A
Director
$0
8.7K sh
Own +14%
-
Sell·S
Director
$161.9K
4.5K sh · $35.97
Own -20%
-
Exercise·M
Director
$0
8.7K sh
Own New
-
Sell·S
Director
$323.5K
8.7K sh · $37.18
Own -12%
-
Exercise·M
Director
$143.5K
8.7K sh · $16.49
Own +14%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Gino Santini | Exercise M | 8.7K | $0 |
| Jun 8, 2026 | Gino Santini | Exercise M | 8.7K | $143.5K |
| May 21, 2026 | Garen G Bohlin | Grant A | 15.5K | $0 |
| May 18, 2026 | John Gordon Freund | Sell S | 20 | $681 |
| May 15, 2026 | John Gordon Freund | Exercise M | 8.7K | $0 |
| May 15, 2026 | John Gordon Freund | Sell S | 4.1K | $142.5K |
| May 15, 2026 | John Gordon Freund | Exercise M | 8.7K | $143.5K |
| May 14, 2026 | Donovan Michael Glancy | Grant A | 17.5K | $0 |
| May 14, 2026 | Carlos V Paya | Grant A | 8.7K | $0 |
| May 14, 2026 | Nancy Lurker | Grant A | 8.7K | $0 |
| May 14, 2026 | John Gordon Freund | Grant A | 8.7K | $0 |
| May 14, 2026 | Gino Santini | Grant A | 8.7K | $0 |
| May 14, 2026 | Rita J. Balice-Gordon | Grant A | 8.7K | $0 |
| May 14, 2026 | Garen G Bohlin | Grant A | 8.7K | $0 |
| May 13, 2026 | Nancy Lurker | Sell S | 4.5K | $161.9K |
| May 11, 2026 | Garen G Bohlin | Exercise M | 8.7K | $0 |
| May 11, 2026 | Garen G Bohlin | Sell S | 8.7K | $323.5K |
| May 11, 2026 | Garen G Bohlin | Exercise M | 8.7K | $143.5K |
About COLL insider trading
This page tracks insider transactions for COLLEGIUM PHARMACEUTICAL, INC (COLL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.